Dear Presenters,

On behalf of the 23^rd ICRAV Organising Committee, we extend our heartfelt appreciation for your invaluable contributions to the success of the conference.  Although ICRAV 2023 has concluded, the ICRAV 2023 Proceedings continue to play a vital role in facilitating the exchange of ideas and promoting the advancement of knowledge. We would like to express our gratitude to the presenters who have already submitted their manuscripts.

We understand that some presenters may be facing time constraints due to their professional commitments, making it challenging to meet the manuscript submission deadline. In response to these requests, the Organising Committee has decided to extend the deadline for manuscript submissions to 31 January 2024, at the latest. If you wish for your manuscript to be considered for publication in the special issue of Drug Testing and Analysis (DTA), please submit your manuscript for the Proceedings by 31 December 2023. The Organising Committee will review the submissions and extend invitations to the presenters of selected manuscripts for submission to DTA by mid-January 2024.

For detailed guidelines on manuscript preparation, please refer to the author guidelines available on the conference website: https://www.icrav2023.com/en/author-guidelines.  We look forward to receiving your manuscript at chantalgg@intnet.mu and info@icrav2023.com. 

Thank you once again for your valuable contributions, and we look forward to receiving your manuscripts.

Kind regards,

Emmie Ho

Chair of the 23^rd ICRAV Organising Committee